Corcept Therapeutics Inc. (CORT) Reports In-Line Q4 Loss
Tweet Send to a FriendGet Alerts CORT Hot Sheet
Price: $1.83 +1.10%
EPS Growth %: +23.1%
Financial Fact:
Net loss and comprehensive loss: -12.08M
Today's EPS Names:
CO, JW-A, FDS, More
EPS Growth %: +23.1%
Financial Fact:
Net loss and comprehensive loss: -12.08M
Today's EPS Names:
CO, JW-A, FDS, More
Trade CORT Now!
Corcept Therapeutics Inc. (NASDAQ: CORT) reported Q4 loss of $0.10, in-line with the analyst estimate of ($0.10).
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Factset Research Systems (FDS) Reports In-Line Q3 EPS; Guides Q4 EPS, Revs
- John Wiley (JW-A) Misses Q4 EPS by 9c; Names New CFO; Updates on Restructuring
- Tough Print Market Leads Tribune to Lower Profits in FY12 (NWSA)
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
